Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 59.33
+2.65 (4.68%)
Mar 10, 2026, 2:55 PM CST
SHA:688336 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 459.49 | 933.26 | 1,091 | 1,614 | Upgrade
|
| Short-Term Investments | - | 863.59 | 344.19 | - | - | Upgrade
|
| Trading Asset Securities | - | 910.54 | 603.87 | 1,486 | 752.05 | Upgrade
|
| Cash & Short-Term Investments | 1,724 | 2,234 | 1,881 | 2,577 | 2,366 | Upgrade
|
| Cash Growth | -22.83% | 18.73% | -27.00% | 8.93% | -14.31% | Upgrade
|
| Accounts Receivable | - | 147.14 | 133.24 | 149.35 | 256.97 | Upgrade
|
| Other Receivables | - | 0.03 | 0.2 | 0.29 | 0.53 | Upgrade
|
| Receivables | - | 147.17 | 133.44 | 149.65 | 257.5 | Upgrade
|
| Inventory | - | 229.6 | 194.96 | 227 | 210.14 | Upgrade
|
| Other Current Assets | - | 49.64 | 40.09 | 32.54 | 38.09 | Upgrade
|
| Total Current Assets | - | 2,660 | 2,250 | 2,986 | 2,872 | Upgrade
|
| Property, Plant & Equipment | - | 1,539 | 1,562 | 1,426 | 1,371 | Upgrade
|
| Long-Term Investments | - | 1,140 | 1,020 | 109.4 | 122.37 | Upgrade
|
| Goodwill | - | 0.64 | 0.64 | 0.64 | 0.64 | Upgrade
|
| Other Intangible Assets | - | 223.96 | 240.16 | 195.73 | 196.55 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 129.62 | 145.74 | 173.43 | 155.31 | Upgrade
|
| Long-Term Deferred Charges | - | 228.54 | 44.44 | 114.02 | 97.67 | Upgrade
|
| Other Long-Term Assets | - | 43.68 | 42.16 | 92.76 | 73.59 | Upgrade
|
| Total Assets | - | 5,965 | 5,305 | 5,098 | 4,889 | Upgrade
|
| Accounts Payable | - | 34.96 | 21.93 | 15.91 | 16.27 | Upgrade
|
| Accrued Expenses | - | 174.93 | 181.2 | 56.18 | 127.71 | Upgrade
|
| Short-Term Debt | - | 50.02 | 50.03 | 150.1 | - | Upgrade
|
| Current Income Taxes Payable | - | 1.3 | 1.3 | 1.2 | 0.21 | Upgrade
|
| Current Unearned Revenue | - | 20.2 | 16.77 | 19.55 | 3.25 | Upgrade
|
| Other Current Liabilities | - | 35.49 | 36.91 | 132.15 | 68.01 | Upgrade
|
| Total Current Liabilities | - | 316.91 | 308.14 | 375.09 | 215.45 | Upgrade
|
| Long-Term Unearned Revenue | - | 111.24 | 118.33 | 123.79 | 134.28 | Upgrade
|
| Total Liabilities | - | 428.15 | 426.47 | 498.88 | 349.73 | Upgrade
|
| Common Stock | - | 616.79 | 616.79 | 616.79 | 616.21 | Upgrade
|
| Additional Paid-In Capital | - | 2,310 | 2,303 | 2,309 | 2,301 | Upgrade
|
| Retained Earnings | - | 2,639 | 1,985 | 1,691 | 1,641 | Upgrade
|
| Comprehensive Income & Other | - | 2.44 | -8.71 | -10.67 | -17.33 | Upgrade
|
| Total Common Equity | 5,899 | 5,568 | 4,896 | 4,606 | 4,542 | Upgrade
|
| Minority Interest | - | -30.76 | -17.58 | -6.32 | -2.46 | Upgrade
|
| Shareholders' Equity | 5,859 | 5,537 | 4,879 | 4,600 | 4,539 | Upgrade
|
| Total Liabilities & Equity | - | 5,965 | 5,305 | 5,098 | 4,889 | Upgrade
|
| Total Debt | - | 50.02 | 50.03 | 150.1 | - | Upgrade
|
| Net Cash (Debt) | 1,724 | 2,184 | 1,831 | 2,427 | 2,366 | Upgrade
|
| Net Cash Growth | -21.06% | 19.24% | -24.55% | 2.59% | -14.31% | Upgrade
|
| Net Cash Per Share | 2.79 | 3.53 | 2.98 | 3.94 | 3.93 | Upgrade
|
| Filing Date Shares Outstanding | 628.61 | 616.79 | 616.79 | 616.79 | 616.21 | Upgrade
|
| Total Common Shares Outstanding | 616.79 | 616.79 | 616.79 | 616.79 | 616.21 | Upgrade
|
| Working Capital | - | 2,343 | 1,942 | 2,611 | 2,656 | Upgrade
|
| Book Value Per Share | 9.56 | 9.03 | 7.94 | 7.47 | 7.37 | Upgrade
|
| Tangible Book Value | 5,685 | 5,343 | 4,655 | 4,409 | 4,344 | Upgrade
|
| Tangible Book Value Per Share | 9.22 | 8.66 | 7.55 | 7.15 | 7.05 | Upgrade
|
| Buildings | - | 626.77 | 626.77 | 531.48 | 531.48 | Upgrade
|
| Machinery | - | 1,220 | 1,196 | 1,043 | 1,035 | Upgrade
|
| Construction In Progress | - | 749.65 | 687.81 | 717.11 | 572.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.